60 bpm
−11bpm vs. vs prior 7d
Patient 1 (Henrik)
Summary
Clinical context
- Date of birth
- 1989-11-05
- Conditions
-
- MDS-AML (2023)
- Allogeneic HSCT 2023-11-23
- Chronic multi-organ GvHD
- Hepatitis E virus (diagnosed 2026-03-18)
- Current medications
-
- Ruxolitinib 10mg BID (since 2026-03-16)
- Bisoprolol 2.5mg daily (since 2026-04-08)
Vitals snapshot
Key indicators, 7-day rolling
28 ms
−1ms vs. vs prior 7d
82,3 %
+0,2% vs. vs prior 7d
0,17 C
−0,07C vs. vs prior 7d
Causal inference
Statistical tests
Ruxolitinib intervention response, causal impact at 2026-03-16:
- HRV (mean RMSSD): p<0.001
- Resting HR (lowest): p=0.002
- SpO2 average: p=0.324
Source: statistical_tests for analysis_key causal_timeseries.
ADSI:Autonomic Dysfunction Severity Index. Higher means more dysfunction.
Actions